Febuxostat high quality CAS:144060-53-7 USP/EP

Shandong Fengjin Beauty Biotech is a chemical company，a multi-grade raw material supplier for medicine, food and cosmetics. We sell HA, PGA, Recombinant collagen, EGT, Ceramides, Ectoine. ect. 
Dr. Zhu Xiqiang，the CEO of Fengjin Beauty Biotech is the first scientist in the world to discover that polyglutamic acid has a whitening mechanism. After several years of in-depth research on polyglutamic acid, several derivative raw materials have been developed for this ingredient. At the same time, under the leadership of Dr. Zhu Xiqiang, its R&D team has also made major breakthroughs in the fermentation and extraction process of collagen and PDRN.
You're welcome to contact with us about pharma and raw materials.

An antigout drug used in gout patients with hyperuricemia

Anti-gout drug, used for hyperuricemia in patients with gout. This product is a 2-arylthiazole derivative and a xanthine oxidase inhibitor that reduces serum uric acid concentration by inhibiting uric acid synthesis. Basic Information:
CAS number: 144060-53-7
English name:Febuxostat
English synonyms: FBX;Uloric;
Chinese name: Febuxostat
Chinese synonyms: febuxostat; febuxostat;
CBNumber:CB4841564
Molecular formula: C16H16N2O3S
Molecular weight: 316.37
Appearance: white to off-white crystalline powder

Febuxostat is a new generation of xanthine oxidase inhibitor developed by Teijin Corporation of Japan. It is clinically used to treat hyperuricemia (gout). Its structure is similar to the xanthine oxidase inhibitor drug developed 40 years ago. Completely different, it is a new and highly effective non-purine xanthine oxidase selective inhibitor. Xanthine oxidase is the key enzyme that promotes uric acid production. Febuxostat can reduce the level of Chemicalbook uric acid in the blood of hyperuricemic gout patients. Clinical studies have shown that this product is safe and effective. This product is metabolized by the liver and does not rely on renal excretion, so it is suitable for moderate to severe liver and kidney function. Incomplete patients also do not require dose reduction. The dosage is 40 mg or 80 mg once daily and is not recommended for the treatment of gout patients without hyperuricemia. In February 2009, the U.S. Food and Drug Administration (FDA) approved febuxostat for the long-term treatment of patients with gout and hyperuricemia.

Febuxostat is a drug that reduces the production of uric acid. You must follow the doctor's advice when taking it. This drug can reduce the synthesis of uric acid in the body and is a commonly used drug for the treatment of gout. It can improve patients' gout symptoms. When taking febuxostat, patients must follow the doctor's advice and should not increase or decrease the dosage at will to avoid poor treatment effects.

Treatment of hyperuricemia (gout)

  Conclusion: This product was tested accordance with SOP-QS101

Q1 What’s your MOQ?
A:Usually 1 kg，It’s depend on different products. We accept sample order. Also for some products we can provide you with free sample.
Q2 How to control and quality assurance?
a.High grade clean workshop.
b. Inspection center equipped with instruments of HPLC, GC etc, R&D and QC for testing of each batch.
c. Cooperated with third-party test agency for testing heavy metals, pesticide residues, allergen etc.
Q3 what kind of payment do you support?
T/T, Trade Assurance, Paypal, Western Union,Alipay, Credit Card, L/C etc.
Q4 What's your shipping methods and delivery time?
a.Shipping Methods: DHL/Fedex/Air Shipping/Sea Shipping
b.Shipping Time: 3-5 days by air or 7-14 days by sea
Q5 How to qaurantee the after-sale?
a.We provide 24-hour customer service. If you encounter any product quality problems or transportation problems, please feel free to contact us
b.lf any problem happens after sale, either quality or quantity, we will try to solve it instantly.and we even have recall system if necessary.